
June 29 (Reuters) - KKR & Co Inc KKR.N:
TORRENT PHARMA TO ACQUIRE CONTROLLING STAKE IN J. B. CHEMICALS & PHARMACEUTICALS FROM KKR
KKR & CO INC - TORRENT TO BUY 46.39% STAKE IN JB PHARMA FOR INR 11,917 CRORES
KKR & CO INC - DEAL VALUED AT INR 25,689 CRORES
KKR & CO INC - TORRENT INTENDS TO BUY ADDITIONAL 2.80% EQUITY SHARES
KKR & CO INC - OPEN OFFER PRICE SET AT INR 1,639.18 PER SHARE
KKR & CO INC - JB PHARMA SHAREHOLDERS TO RECEIVE 51 TORRENT SHARES FOR EVERY 100 JB PHARMA SHARES